REVOSIMELINE HYDROCHLORIDE
UNII E3825IX0LW

Substance Identification & Data

This profile provides standardized clinical and technical data for Revosimeline Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) E3825IX0LW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2232226-19-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

E3825IX0LW

CAS Registry Number

2232226-19-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REVOSIMELINE HYDROCHLORIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H29N3O3.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

SWXZEBGVRUGRQW-NCLQARKCSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C223447

National Cancer Institute reference terminology for clinical and research data.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1C2(CCN(C1)[C@H]3C[C@@H]4N([C@H](C3)CC4)C(OCC)=O)CC(NC2)=O.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Revosimeline Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.